Harvard Bioscience (HBIO) Change in Inventory (2010 - 2026)
Harvard Bioscience (HBIO) reported Change in Inventory of $1.5 million for Q1 2026, up 329.85% year-over-year from $358263.9 in Q1 2025, and up 332.28% quarter-over-quarter from -$663000.0 in Q4 2025.
Harvard Bioscience (HBIO) Change in Inventory (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of Change in Inventory data on file, last reported at $1.5 million in Q1 2026.
- Change in Inventory for Q1 2026 came in at $1.5 million, up 329.85% year-over-year; the trailing twelve-month figure through Mar 2026 was -$737000.0 (up 39.74% YoY), and the FY2025 annual result was -$2.9 million, down 4704.69% from the prior year.
- Change in Inventory grew to $1.5 million in Q1 2026 per HBIO's latest filing, from -$663000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $1.5 million in Q1 2026 and troughed at -$2.4 million in Q4 2024.
- A 5-year average of -$183470.6 and a median of -$581000.0 in 2022 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2022 and 2026: Change in Inventory sank 253.61% in 2022, then soared 329.85% in 2026.
- A 5-year view of Change in Inventory shows it stood at -$581000.0 in 2022, then slumped by 132.53% to -$1.4 million in 2023, then slumped by 74.09% to -$2.4 million in 2024, then soared by 71.81% to -$663000.0 in 2025, then surged by 332.28% to $1.5 million in 2026.
- Business Quant data shows HBIO's Change in Inventory at $1.5 million in Q1 2026, -$663000.0 in Q4 2025, and -$637000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 266.60 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 42.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -12.48 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 32.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -9.35 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 95.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | 1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.54 Mn |
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | -663,000.00 |
| Dec 31, 2025 | -663,000.00 |
| Sep 30, 2025 | -637,000.00 |
| Sep 30, 2025 | -637,000.00 |
| Jun 30, 2025 | -977,000.00 |
| Jun 30, 2025 | -977,000.00 |
| Mar 31, 2025 | -670,000.00 |
| Mar 31, 2025 | -670,000.00 |
| Dec 31, 2024 | -2.35 Mn |
| Dec 31, 2024 | -2.35 Mn |
| Sep 30, 2024 | 668,000.00 |
| Sep 30, 2024 | 668,000.00 |
| Jun 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 1.13 Mn |
| Mar 31, 2024 | 617,000.00 |
| Mar 31, 2024 | 617,000.00 |
| Dec 31, 2023 | -1.35 Mn |
| Dec 31, 2023 | -1.35 Mn |